Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04216732 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management

StatusRecruiting
PhaseNot specified
Started2020-01-10
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 24 months later Sep 1, 2026 → Sep 1, 2028
See other at-risk trials from M.D. Anderson Cancer Center

Amendment history

2026-09-26
Primary completion pushed: 2026-09-01 → 2028-09-01
Completion pushed: 2026-09-01 → 2028-09-01
2026-03-03
5 amendments v7-v11
5 re-verifications since 2024-08-23, no change to tracked fields
2024-02-21
Study Status v6
Primary completion date2023-09-01→2026-09-01
Completion date2023-09-01→2026-09-01
2023-08-22
Study Status v5
Re-verified, no change to tracked fields
2020-08-27
Study Status, Oversight, Study Description, Arms and Interventions, Outcome Measures, Eligibility, Contacts/Locations v4
InterventionsBlood Pressure (Other), Questionnaire Administration (Other)→Blood Pressure Measurement (Other), Questionnaire Administration (Other)
Eligibility criteria+1 characters
[...] ermined by clinical team Aim 3: A current registrant in the MTCMTCR
Study description+27 characters
[...] o blood pressure measurements every day for up to 12 weeks. AfterThe completionquestionnaire ofdata study,gets patientspaired arewith followedthe upcollected everymedical 6record monthshistory forthat upis tomaintained 3in yearsthe Registry.
Study sitescontacts updated at 1 of 2 sites
Show 3 earlier versions
2020-07-23
Study Identification, Study Status, Contacts/Locations v3
Primary completion date2022-09-01→2023-09-01
Completion date2022-09-01→2023-09-01
Study sites1→2
2020-07-21
Study Status, Sponsor/Collaborators, Oversight, Study Description, Outcome Measures, Eligibility v2
Eligibility criteria-39 characters
Inclusion Criteria: Aims 1 and 2: A diagnosis of MTC Aims 1 and 2: age >/= 18 years Aims 1 and 2: aA registrant in the Medullary Thyroid Cancer Registry (MTCR). Patients of all disease phases will be eligible for enrollment. Aim 3: A diagnosis of advanced phase (red or gray) MTC as determined by clinical team Aim 3: age >/= 18 Aim 3: aA current registrant in the MTC Exclusion Criteria: None
Primary endpoints4 to 3 entries
Association of selected biometric outcomes Association of selectedand patient-reported outcomes
Study description-15 characters
[...] clinical, pathologic, and genotypic variables collected in the investigator'sour existing multi-institutional patient registry. Ia. To descr [...]
Collaborators2 to 1 entries
Food and Drug Administration (FDA)
2020-07-02
Not Yet Recruiting→Recruiting Study Status, Study Description, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2020-04-30→confirmed 2020-01-10
Study sitesdetails revised at 1 of 1 site
2020-01-02
Original filing
This study utilizes a multi-institutional registry to describe the natural history of medullary thyroid cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) in understanding disease management. The goal of this study is to learn about how medullary thyroid cancer develops and progresses.
Trial Details
NCT Number NCT04216732
Lead Sponsor M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)
Conditions Advanced Thyroid Gland Medullary Carcinoma, Stage III Thyroid Gland Medullary Carcinoma AJCC v8, Stage IV Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8
Enrollment 2,030 participants
Start Date 2020-01-10
Primary Completion 2028-09-01 (estimated)
Study Completion 2028-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-25